Neurogene Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 1.72 M | $20.11 M | 0.00% | 8.18% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 1.49 M | $17.40 M | 120.36% | 7.08% |
BLACKROCK, INC. | 05/02/2025 | 1.40 M | $16.38 M | -7.72% | 6.66% |
RTW INVESTMENTS, LP | 05/15/2025 | 1.35 M | $15.79 M | -0.12% | 6.42% |
REDMILE GROUP, LLC | 05/15/2025 | 1.31 M | $15.32 M | -0.89% | 6.23% |
CASDIN CAPITAL, LLC | 05/15/2025 | 1.30 M | $15.17 M | 0.00% | 6.17% |
ECOR1 CAPITAL, LLC | 05/15/2025 | 1.27 M | $14.89 B | 0.00% | 6.06% |
COMMODORE CAPITAL LP | 05/15/2025 | 925.00 K | $10.83 M | 15.63% | 4.41% |
VANGUARD GROUP INC | 05/09/2025 | 617.94 K | $7.24 M | 8.79% | 2.94% |
GREAT POINT PARTNERS LLC | 05/15/2025 | 470.96 K | $5.51 M | 6.37% | 2.24% |
FMR LLC | 05/12/2025 | 462.88 K | $5.42 M | -46.20% | 2.20% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 446.88 K | $5.23 M | -0.28% | 2.13% |
ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 441.59 K | $5.17 M | -1.56% | 2.10% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 303.00 K | $3.55 M | 0.00% | 1.44% |
MORGAN STANLEY | 05/15/2025 | 286.11 K | $3.35 M | -13.26% | 1.36% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 259.38 K | $3.04 M | 10.55% | 1.24% |
TORONTO DOMINION BANK | 05/15/2025 | 239.26 K | $2.80 M | 100.00% | 1.14% |
STATE STREET CORP | 05/15/2025 | 230.54 K | $2.70 M | 2.29% | 1.10% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 200.00 K | $2.34 M | 100.00% | 0.95% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 157.94 K | $1.85 M | 100.00% | 0.75% |
BLAIR WILLIAM & CO/IL | 05/09/2025 | 151.18 K | $1.77 M | 141.35% | 0.72% |
DEUTSCHE BANK AG\ | 05/09/2025 | 150.86 K | $1.77 M | -0.99% | 0.72% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 116.66 K | $1.37 M | 100.00% | 0.56% |
NORTHERN TRUST CORP | 05/13/2025 | 110.41 K | $1.29 M | 9.79% | 0.53% |
JENNISON ASSOCIATES LLC | 05/05/2025 | 108.08 K | $1.27 M | 48.88% | 0.51% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 104.34 K | $1.22 B | 9.36% | 0.50% |
WALLEYE CAPITAL LLC | 05/14/2025 | 94.08 K | $1.10 M | 25.72% | 0.45% |
JPMORGAN CHASE & CO | 05/12/2025 | 86.98 K | $1.02 M | -81.92% | 0.41% |
WOODLINE PARTNERS LP | 05/15/2025 | 83.41 K | $976.73 K | 0.08% | 0.40% |
UBS OCONNOR LLC | 05/15/2025 | 56.02 K | $655.94 K | 71.12% | 0.27% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 52.52 K | $615.02 K | 98.14% | 0.25% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 51.50 K | $603.07 K | 0.00% | 0.25% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 43.70 K | $511.73 K | 130.00% | 0.21% |
CITADEL ADVISORS LLC | 05/15/2025 | 40.60 K | $475.43 K | 30.13% | 0.19% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 34.42 K | $403.07 K | 58.50% | 0.16% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 33.97 K | $397.78 K | 12.05% | 0.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 33.00 K | $386.43 K | -82.87% | 0.16% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 32.77 K | $383.68 K | 0.00% | 0.16% |
05/09/2025 | 30.00 K | $435.60 K | 87.50% | 0.14% | |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 27.93 K | $327.00 K | 100.00% | 0.13% |
05/12/2025 | 27.48 K | $321.82 K | 100.00% | 0.13% | |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 24.45 K | $286.26 K | 8.16% | 0.12% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 21.18 K | $247.97 K | -44.36% | 0.10% |
MARSHALL WACE, LLP | 05/15/2025 | 17.55 K | $205.53 K | 100.00% | 0.08% |
CITADEL ADVISORS LLC | 05/15/2025 | 16.42 K | $192.23 K | 100.00% | 0.08% |
RHUMBLINE ADVISERS | 04/08/2025 | 15.69 K | $183.75 K | -0.07% | 0.07% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 14.41 K | $168.68 K | -80.74% | 0.07% |
BARCLAYS PLC | 05/15/2025 | 14.23 K | $167.00 K | -18.84% | 0.07% |
ENTRYPOINT CAPITAL, LLC | 05/14/2025 | 12.67 K | $148.32 K | 100.00% | 0.06% |
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 05/12/2025 | 11.23 K | $131.52 K | 9.14% | 0.05% |
Neurogene Inc. institutional Ownership - FAQ's
During the previous two years, 95 institutional investors and hedge funds held shares of Neurogene Inc.. The most heavily invested institutionals were:
Samsara BioCapital, LLC: 1.72 M
BAKER BROS. ADVISORS LP: 1.49 M
BlackRock, Inc.: 1.4 M
RTW INVESTMENTS, LP: 1.35 M
Redmile Group, LLC: 1.31 M
Casdin Capital, LLC: 1.3 M
78.38% of Neurogene Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.66 M shares in the last 24 months. This purchase volume represents approximately $311.88 M in transactions.